SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-13-138129
Filing Date
2013-04-02
Accepted
2013-04-02 13:10:42
Documents
6
Period of Report
2013-05-22

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d514938dpre14a.htm PRE 14A 719080
2 GRAPHIC g514938g55f18.jpg GRAPHIC 19397
3 GRAPHIC g514938g56o58.jpg GRAPHIC 15690
4 GRAPHIC g514938g81s56.jpg GRAPHIC 15153
5 GRAPHIC g514938g82h68.jpg GRAPHIC 41550
6 GRAPHIC g514938g88c72.jpg GRAPHIC 44768
  Complete submission text file 0001193125-13-138129.txt   909286
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: PRE 14A | Act: 34 | File No.: 001-32302 | Film No.: 13734326
SIC: 3841 Surgical & Medical Instruments & Apparatus